Home › Anal Cancer › Tennessee › Nashville
Anal Cancer clinical trials in Nashville, TN
5 studies for Anal Cancer are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Tennessee Oncology, Nashville
SMP-3124LP in Adults With Advanced Solid Tumors
RecruitingPhase 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Nashville
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RecruitingPhase 1
- SCRI, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RecruitingPhase 1/2
- Tennessee Oncology, Nashville
About Anal Cancer
Anal cancer is rare. HPV is one of the most common causes. Find out more about anal cancer symptoms, diagnosis, and treatment.
More about Anal Cancer on MedlinePlus
Anal Cancer trials in other cities
- Houston, TX6 studies
- Los Angeles, CA5 studies
- New York City, NY5 studies
- Edison, NJ5 studies
- San Francisco, CA5 studies
- Chicago, IL3 studies
- Cleveland, OH3 studies
- Atlanta, GA3 studies
- Queens, NY3 studies
- Washington, DC3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer78 studies
- Metastatic Cancer69 studies
- Colorectal Cancer67 studies
- Cancer (all types)65 studies
- Ovarian Cancer50 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Prostate Cancer40 studies
- Pancreatic Cancer39 studies
- Lung Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.